Abstract
Abstract
A Langendorff perfused rat heart preparation was designed to process dose-response effects of cardioactive drugs on rate, coronary flow, and supraaortic differential pressure (ΔP; an index of cardiac performance). In this preparation, Δ9--tetrahydrocannabinol (THC) 2 × 10-6 M to 10-5 M induces in the isolated perfused rat heart a biphasic increase in rate (maximal at 8 × 10-6 M). Tachycardia is associated with decreases in (ΔP) and no change or decreased coronary flow. Cardiac toxicity is observed with 3 × 10-5 M. Cannabidiol (CBD) at concentrations of 9 × 10-6 M to 10-4 M has limited effect on rate while increasing ΔP and coronary flow. Cannabinol (CBN) 8 × 10-6 M to 3 × 10-4 M depresses rate and ΔP while coronary flow remains constant. Simultaneous equimolar administration of THC with CBD antagonizes or mitigates the cardiac effects of THC on rate, ΔP, and coronary flow.
Get full access to this article
View all access options for this article.